The global biotherapeutic virus removal filters market is set to witness significant growth, with its valuation projected to surge from USD 451.2 million in 2023 to USD 972.6 million by 2033, expanding at a CAGR of 8.0% during the forecast period.
This expansion is driven by the rapid growth of the biotechnology and pharmaceutical industries, which continue to thrive due to factors such as aging populations, the rising prevalence of chronic diseases, and increasing healthcare expenditures. As biopharmaceutical companies scale up production, the need for robust viral clearance procedures becomes more critical to ensure the safety and purity of biologics, including recombinant proteins, monoclonal antibodies, and vaccines.
Discover Market Shifts: Secure Your Sample Report Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d36303534
Role of Contract Manufacturing Organizations (CMOs) in Market Growth
With a focus on cost efficiency and specialization, biopharmaceutical firms are increasingly outsourcing manufacturing to Contract Manufacturing Organizations (CMOs). To meet the rising demand for biologics, CMOs are investing in advanced virus removal filtration technologies, further propelling market expansion.
Increasing Adoption of Single-Use Bioprocessing Technologies
The shift toward single-use bioprocessing systems is another key driver of market growth. These systems offer advantages such as cost-effectiveness, reduced cross-contamination risks, and greater flexibility in manufacturing. As more biopharmaceutical manufacturers adopt single-use virus removal filters, the market is expected to witness sustained demand.
Growing Pipeline of Biologic Drugs to Drive Demand
The biopharmaceutical sector continues to develop a strong pipeline of biologic drugs targeting unmet medical needs. As these drugs progress through clinical trials and secure regulatory approvals, the demand for high-performance virus removal filters is anticipated to rise, supporting large-scale production.
Key Takeaways from Biotherapeutic Virus Removal Filters Market Report
- In 2018, the global market size stood at USD 320.4 million.
- The market expanded at a CAGR of 5.8% from 2018 to 2022.
- In 2022, the global market size stood at USD 424.3 million.
- The size exclusion technology segment captured 57.30% of global market shares in 2022.
- The biopharmaceutical companies segment acquired 43.8% of global market shares in 2022.
- India captured 8.5% of global market shares in 2022.
- The United States captured 29.3% of global market shares in 2022.
- China captured 10.4% of global market shares in 2022.
- The United Kingdom captured 6.0% of global market shares in 2022.
Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report! https://www.futuremarketinsights.com/reports/biotherapeutics-virus-removal-filters-market
Competitive Landscape
The global biotherapeutics virus removal filters market is highly competitive, with key players including Pall Corporation, Z-Medica LLC, Asahi Kasei Corporation, Merck KGaA, and Sartorius AG, among others.
Due to the presence of numerous market participants, competition remains intense. Major global companies such as Pall Corporation, Z-Medica LLC, and Asahi Kasei Corporation hold a significant market share, while several regional players are also expanding their presence, particularly in high-growth areas like the Asia-Pacific region.
Recent Developments
- April 2022 – Merck expanded its bioprocessing portfolio by acquiring the MAST® platform, introducing fully automated sampling to its offerings.
- December 2021 – Asahi Kasei Medical Co., Ltd. acquired Bionique Testing Laboratories LLC, strengthening its capabilities in biological testing.
Biotherapeutics Virus Removal Filters Market Segmentation
By Technology:
- Size Exclusion Technology
- Depth Filtration Technology
By Application:
- Monoclonal Antibodies
- Blood & Plasma
- Enzymes
- Proteins
By End-user:
- Biopharmaceutical Companies
- Clinical Research Organizations
- Academic Institutions
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
Understand the Future of Healthcare with Our Analysis! https://www.futuremarketinsights.com/industry-analysis/life-science-and-biotechnology
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
